High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 2, 1999, Pages 174-179

  Böni, Jürg ^a   Pyra, Halina ^a   Gebhardt, Martin ^b   Perrin, Luc ^c   Bürgisser, Philippe ^d   Matter, Lukas ^e   Fierz, Walter ^f   Erb, Peter ^g   Piffaretti, Jean Claude ^h   Minder, Elisabeth ⁱ   Grob, Peter ^a   Burckhardt, Johann J ^j   Zwahlen, Marcel ^b   Schüpbach, Jörg ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g UNIVERSITY OF BASEL   (Switzerland)

^h Istituto Batteriosierologico Cantonale   (Switzerland)

ⁱ Triemli City Hospital   (Germany)

^j Central Laboratory in Bern   (Switzerland)

more..

Author keywords

Epidemiology; Genetic analysis; HIV 1 subtypes; Molecular epidemiology; Switzerland

Indexed keywords

ADULT; ARTICLE; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SWITZERLAND; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION; VIRUS TYPING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0345044896     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199910010-00010     Document Type: Article

References (33)

1. Hamers FF, Batter V, Downs AM, Alix J, Cazein F, Brunet JB. The HIV epidemic associated with injecting drug use in Europe: geographic and time trends. AIDS 1997;11:1365-74.
2. Schupbach J, Vogt M, Bhushan R, et al. Prevalence of antibodies against HTLV-III in various regions in Switzerland [in German]. Schweiz Med Wochenschr 1985;115:1048-54.
3. Schupbach J, Haller O, Vogt M, et al. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med 1985;312:265-70.
4. Anonymous. AIDS und HIV in der Schweiz. Epidemiologische Situation Ende 1997. Berne: Swiss National government, Bundesamt für Gesundheit, 1998.
5. Deiss V, von Overbeck J, Furrer HJ, Germann D, Matter L, Telenti A. Epidemiology of HIV-1 infection in Bern - application of molecular methods [in German]. Schweiz Med Wochenschr 1994;124: 539-44.
6. Antonioli IM, Baumberger C, Yerly S, Perrin L. V3 sequences in primary HIV-1 infection. AIDS 1995;9:11-7.
7. Kalish M, Stoeckli T, Steffen I, Brown TM, Erb P, Kalish ML. Molecular Epidemiology of HIV-1 in Switzerland [abstract 13207]. Presented at the XII World AIDS Conference, Geneva, 1998.
8. Delwart EL, Shpaer EG, Louwagie J, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 1993;262:1257-61.
9. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-25.
10. Debyser Z, Vanwijngaerden E, Vanlaethem K, et al. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV Type 1 subtype G strain. AIDS Res Hum Retroviruses 1998;14:453-9.
11. Simons P, Muyldermans G, Lacor P, Zissis G, Lauwers S. False-negative HIV viral load in AIDS patients. AIDS 1997;11:1783-4.
12. Loveday C, Devereux H, Burke A, Dann L, Phillips A, Johnson M. The prevalence of HIV-1 non-B subtypes in a London HIV/AIDS outpatient clinic: the implications for clinical care [abstract 42167], Presented at the XII World AIDS Conference, Geneva, 1998.
13. Barin F, Courouce AM, Pillonel J, et al. Increasing diversity of HIV-1(M) serotypes in French blood donors over a 10-year period (1985-1995). AIDS 1997;11:1503-8.
14. Barin F, Pillonel J, Buzelay L, Corouce AM. Increasing diversity of HIV-1 serotypes in French blood donors (1985-1996) [abstract 13204]. Presented at the XII World AIDS Conference, Geneva, 1998.
15. Couturier E, Damond F, Simon F, Fleury H, Brunei JB. Prevalence of HIV-1 subtypes in France, 1996-1997 [abstract 13199]. Presented at the XII World AIDS Conference, Geneva, 1998.
16. Reynes J, Peeters M, Segondy M, Delaporte E. HIV-1 clade distribution in southern France [abstract 13193]. Presented at the XII World AIDS Conference, Geneva, 1998.
17. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
18. Cheingsongpopov R, Osmanov S, Pau CP, et al. Serotyping of HIV type 1 infections - definition, relationship to viral genetic subtypes, and assay evaluation. AIDS Res Hum Retroviruses 1998;14: 311-18.
19. Leitner T, Escanilla D, Marquina S, et al. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. Virology 1995;209:136-46.
20. Loussert-Ajaka I, Menu E, Apetrei C, et al. HIV type 1 diversity and the reliability of the heteroduplex mobility assay. AIDS Res Hum Retroviruses 1998;14:877-83.
21. Nasioulas G, Paraskevis D, Paparizos V, Lazanas M, Karafoulidou A, Hatzakis A. Genotypic characterization of human immunodeficiency virus type 1 in Greece. AIDS Res Hum Retroviruses 1998; 14:685-90.
22. Coste J, Montes B, Reynes J, et al. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Med Virol 1996;50:293-302.
23. Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999;15:133-42.
24. Triques K, Coste J, Perret JL, et al. Efficiency of three versions of the AMPLICOR HIV-1 monitor test with new gag primers, and a prototype automated version to quantitate NIV-1 RNA from different genetic subtypes [abstract 41145]. Presented at the XII World AIDS Conference, Geneva, 1998.
25. Michael V, Anderegg G, Campbell F, Amor AF. Viral load assays and HIV-1 subtypes in European clinical trials [abstract 42155]. Presented at the XII World AIDS Conference, Geneva, 1998.
26. Soto-Ramirez LE, Renjifo B, McLane MF, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996;271:1291-3.
27. Dittmar MT, Simmons G, Hibbitts S, et al. Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J Virol 1997; 71:8008-13.
28. Pope M, Frankel SS, Mascola JR, et al. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. J Virol 1997;71:8001-7.
29. Fenyo EM, Bjorndall A, Ayehunie S, Sonneborg A. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS-patients [abstract 60692]. Presented at the XII World AIDS Conference, Geneva, 1998.
30. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-8.
31. Kanki PJ, Hamel DJ, Sankale JL, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999;179:68-73.
32. Bentwich Z, Kalinkovich A, Weisman Z, Burstein R, Podolyako M, Galai N. Infection with different HIV-1 subtypes (B or C) result in similar immune activation, progression and response to treatment [abstract 21105]. Presented at the XII World AIDS Conference, Geneva, 1998.
33. Galai N, Shahar E, Naor O, et al. Comparison of viral load levels between cohorts infected with HIV-1 subtypes B and C [abstract 13314]. Presented at the XII World AIDS Conference, Geneva, 1998.